Chuang Hao-Yuan's Form 4 filing
Belite Bio, Inc (BLTE) · filed Aug 14, 2026
- Accession no.
- 0001193125-26-350218
- Filed
- Aug 14, 2026, 6:10 AM ET
- Trade date
- Aug 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $66.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chuang Hao-YuanCIK 0001992008 | Director, Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | American depositary share | SSaleDisposed | −144 | $180.00 | −$25,920 | 93,656 | Direct | |
| Aug 12, 2026 | American depositary share | SSaleDisposed | −223 | $180.57 | −$40,267.11 | 93,433 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.